Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6857 |
Remote Similarity |
NPD2127 |
Suspended |
0.6726 |
Remote Similarity |
NPD2928 |
Phase 2 |
0.6545 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.6477 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6409 |
Remote Similarity |
NPD4998 |
Phase 3 |
0.6409 |
Remote Similarity |
NPD4999 |
Phase 3 |
0.6387 |
Remote Similarity |
NPD3918 |
Approved |
0.6387 |
Remote Similarity |
NPD3917 |
Approved |
0.6387 |
Remote Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.6369 |
Remote Similarity |
NPD2136 |
Approved |
0.6369 |
Remote Similarity |
NPD2134 |
Approved |
0.6369 |
Remote Similarity |
NPD2135 |
Approved |
0.6368 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.6368 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.6335 |
Remote Similarity |
NPD3915 |
Approved |
0.6322 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6292 |
Remote Similarity |
NPD2872 |
Phase 2 |
0.6236 |
Remote Similarity |
NPD2814 |
Clinical (unspecified phase) |
0.6126 |
Remote Similarity |
NPD796 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.6096 |
Remote Similarity |
NPD3814 |
Phase 1 |
0.6094 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6092 |
Remote Similarity |
NPD1599 |
Approved |
0.6073 |
Remote Similarity |
NPD4559 |
Clinical (unspecified phase) |
0.6013 |
Remote Similarity |
NPD9080 |
Approved |
0.6011 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.596 |
Remote Similarity |
NPD515 |
Phase 1 |
0.595 |
Remote Similarity |
NPD534 |
Phase 2 |
0.595 |
Remote Similarity |
NPD537 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.5938 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5924 |
Remote Similarity |
NPD9551 |
Approved |
0.5924 |
Remote Similarity |
NPD9550 |
Approved |
0.5918 |
Remote Similarity |
NPD307 |
Approved |
0.5914 |
Remote Similarity |
NPD1173 |
Approved |
0.5912 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5912 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5909 |
Remote Similarity |
NPD9284 |
Approved |
0.5899 |
Remote Similarity |
NPD2293 |
Phase 2 |
0.5897 |
Remote Similarity |
NPD8827 |
Approved |
0.5892 |
Remote Similarity |
NPD1286 |
Suspended |
0.5882 |
Remote Similarity |
NPD1335 |
Approved |
0.5876 |
Remote Similarity |
NPD5065 |
Approved |
0.5876 |
Remote Similarity |
NPD4533 |
Clinical (unspecified phase) |
0.585 |
Remote Similarity |
NPD9360 |
Approved |
0.5839 |
Remote Similarity |
NPD203 |
Clinical (unspecified phase) |
0.5838 |
Remote Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.5838 |
Remote Similarity |
NPD5925 |
Phase 1 |
0.5838 |
Remote Similarity |
NPD5117 |
Phase 2 |
0.5808 |
Remote Similarity |
NPD3976 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.5803 |
Remote Similarity |
NPD2299 |
Phase 1 |
0.5801 |
Remote Similarity |
NPD3593 |
Approved |
0.5787 |
Remote Similarity |
NPD8321 |
Discontinued |
0.5776 |
Remote Similarity |
NPD9506 |
Approved |
0.5775 |
Remote Similarity |
NPD9071 |
Phase 3 |
0.5775 |
Remote Similarity |
NPD3406 |
Suspended |
0.5767 |
Remote Similarity |
NPD1649 |
Discontinued |
0.5765 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5759 |
Remote Similarity |
NPD9726 |
Discontinued |
0.5756 |
Remote Similarity |
NPD704 |
Clinical (unspecified phase) |
0.5754 |
Remote Similarity |
NPD2367 |
Phase 2 |
0.5753 |
Remote Similarity |
NPD3439 |
Approved |
0.5752 |
Remote Similarity |
NPD300 |
Approved |
0.5745 |
Remote Similarity |
NPD5428 |
Discontinued |
0.5741 |
Remote Similarity |
NPD852 |
Discontinued |
0.574 |
Remote Similarity |
NPD3262 |
Approved |
0.5739 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.5737 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.5736 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5731 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.5731 |
Remote Similarity |
NPD1709 |
Phase 1 |
0.5729 |
Remote Similarity |
NPD2536 |
Discontinued |
0.5728 |
Remote Similarity |
NPD7269 |
Clinical (unspecified phase) |
0.5722 |
Remote Similarity |
NPD1235 |
Phase 3 |
0.5722 |
Remote Similarity |
NPD6022 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD1570 |
Approved |
0.5714 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5691 |
Remote Similarity |
NPD1234 |
Discontinued |
0.5691 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.5691 |
Remote Similarity |
NPD6887 |
Clinical (unspecified phase) |
0.5684 |
Remote Similarity |
NPD2482 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.5669 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5669 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5663 |
Remote Similarity |
NPD2317 |
Clinical (unspecified phase) |
0.5663 |
Remote Similarity |
NPD1352 |
Discontinued |
0.5659 |
Remote Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.5649 |
Remote Similarity |
NPD8826 |
Approved |
0.5642 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.5641 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.5635 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5632 |
Remote Similarity |
NPD1912 |
Approved |
0.5632 |
Remote Similarity |
NPD9398 |
Clinical (unspecified phase) |
0.5625 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.5622 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.5622 |
Remote Similarity |
NPD2724 |
Phase 1 |
0.5612 |
Remote Similarity |
NPD944 |
Approved |
0.5611 |
Remote Similarity |
NPD2829 |
Clinical (unspecified phase) |
0.5611 |
Remote Similarity |
NPD4128 |
Approved |
0.561 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5604 |
Remote Similarity |
NPD7202 |
Clinical (unspecified phase) |
0.5603 |
Remote Similarity |
NPD8861 |
Approved |
0.5603 |
Remote Similarity |
NPD8862 |
Approved |
0.5603 |
Remote Similarity |
NPD8859 |
Approved |
0.56
|
Remote Similarity |
NPD8026 |
Phase 1 |